phosphatidylcholines has been researched along with Lipodystrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornell, RB; Dennis, MK; Dhillon, RK; Lee, J; Taneva, SG; Tse, R | 1 |
| Adams, C; Barroso, I; Brown, RJ; Cochran, E; Dev Borman, A; Girousse, A; Gorden, P; Kory, N; Lim, K; O'Rahilly, S; Payne, F; Robbins, A; Russel-Jones, D; Saudek, V; Savage, DB; Semple, RK; Sleigh, A; Walther, TC; Xue, Y | 1 |
| Capaccioli, S; Dini, M; Lulli, M; Pattarino, J; Romano, FM; Witort, EJ | 1 |
3 other study(ies) available for phosphatidylcholines and Lipodystrophy
| Article | Year |
|---|---|
Disease-linked mutations in the phosphatidylcholine regulatory enzyme CCTα impair enzymatic activity and fold stability.
Topics: Animals; Catalysis; Catalytic Domain; Chlorocebus aethiops; Choline-Phosphate Cytidylyltransferase; COS Cells; Crystallography, X-Ray; Humans; Lipodystrophy; Mutation; Osteochondrodysplasias; Phosphatidylcholines; Protein Binding; Protein Folding; Protein Stability; Retinal Dystrophies; Retinitis Pigmentosa | 2019 |
Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease.
Topics: 3T3-L1 Cells; Adipose Tissue; Adolescent; Alleles; Animals; Child; Cholesterol, HDL; Choline-Phosphate Cytidylyltransferase; Computational Biology; Fatty Liver; Female; Glycerophospholipids; Humans; Insulin; Lipids; Lipodystrophy; Mice; Mutation; Phenotype; Phosphatidylcholines; Tissue Distribution | 2014 |
Lipolytic effectiveness of phosphatidylcholine in the treatment of 'buffalo hump' of HIV patients.
Topics: Adipocytes; Adipose Tissue; Antiretroviral Therapy, Highly Active; Cells, Cultured; HIV Infections; Humans; In Vitro Techniques; Lipodystrophy; Lipolysis; Phosphatidylcholines; Sensitivity and Specificity | 2011 |